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positive cocci in clusters. He responded favorably with systemic control of diabetes, topical concentrated cefazolin, concentrated
tobramycin, and intravenous antibiotics. Possibility of infective complications should be considered when using periocular steroids,
especially in diabetics. Strict control of diabetes and aggressive systemic antibiotics favor rapid healing in such cases.
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Diabetic macular edema (DME) is the most common cause
of visual impairment in patients with diabetes mellitus.1
Posterior subtenon triamcinolone acetonide (PST) has been
used effectively in DME, as primary treatment option,2 as
adjuvant to laser, and in refractory cases. It is devoid of most
systemic side effects of steroids with good local delivery. We
report a case of bacterial scleral abscess following PST
injection for DME.
Case report
A 65-year-old diabetic male presented with redness and
pain in right eye for 15 days. He had history of diabetes for
25 years and hypertension for 10 years. He received posterior
subtenon triamcinolone acetonide (20 mg in 0.5 ml) injectionfor cystoid diabetic macular edema 17 days back. The injec-
tion was given by Nozik’s technique with aseptic precaution
using a 26G needle in superotemporal quadrant of right
eye after proper consent. Topical moxifloxacin 0.5% drops
were prescribed after PST in the right eye. The patient did
not undergo any contact procedures including applanation
tonometry or contact lens aided posterior segment laser on
the same day. Best corrected visual acuity (BCVA) at presen-
tation was 6/18 OD and 6/12 OS. Ocular motility was normal.
There was a localized scleral abscess measuring 7 mm ⁄ 5 mm
with mucopurulent discharge at the site of PST on presenta-
tion (Fig. 1). There was no relative afferent pupillary defect
OD. Both eyes were pseudophakic. In either eye, there was
nonproliferative diabetic retinopathy with clinically significant
macular edema. The central macular thickness (Cirrus
HD-OCT, Carl Zeiss Meditec, Dublin, CA) was 331 micron





Figure 1. The scleral abscess was localized at the site of posterior
subtenon triamcinolone.
Scleral abscess following PST injection for DME 131redness, or discharge in the right eye before this episode.
Clinically there was no evidence of previous scleritis, like
scleral thinning. There was no punctal regurgitation in either
eye on pressure over the lacrimal sac region. There was no
history of topical or oral steroid use in the right eye. No
history of systemic immunosuppression was present. There
was no history of intravitreal injections or laser in the right
eye. On presentation, hypertension was well controlled
(Blood Pressure 130/76 mm of Hg) on oral medication and
diabetes was poorly controlled (HbA1c – 11.7%, Fasting
Blood sugar – 369 mg/dl and Post Prandial blood sugar –
435 mg/dl on oral hypoglycemic agents). There was history
of diabetic nephropathy; however, on presentation the
kidney function tests were normal. We optimized diabetes
control in consultation with the endocrinologist who started
insulin. After sending the discharge for Gram stain, KOH stain
and bacterial and fungal culture, the patient was started
empirically on topical concentrated cefazolin 5% 1 hourly,
topical tobramycin 1.3% 1 hourly, intravenous vancomycin
1 g twice daily, and intravenous ceftriaxone 2 g twice daily.
The slough at the site of abscess was cleaned with sterile
moist swab sticks daily. Within 2 days of this empirical
therapy clinical improvement was noted, so we continued
the same medications. The Gram stain showed Gram positive
cocci in clusters, and KOH stain was negative. Both bacterial
and fungal cultures failed to show any growth. After intra-
venous antibiotic therapy for 7 days, the patient was started
on oral co-amoxiclav 625 mg thrice daily for 14 days. With
these medications, the infective scleritis had resolved after
14 days.Discussion
PST is an affordable and effective primary treatment
option for DME especially with cystoid morphology.3 Scleral
abscess following PST in diabetic macular edema is a rarity.
First such occurrence in DME was reported by Oh et al.4 A
62-year-old woman who received PST injection and panreti-
nal photocoagulation for DME with proliferative retinopathy,
developed periocular abscess after one month. She
developed atrophic bulbi despite long term systemic and
topical itraconazole therapy. The causative agent was
Pseudallescheria boydii. The second case, reported by
Sukhija et al.,5 was a 54-year-old female with poorlycontrolled diabetes. She developed orbital abscess due to
Gram positive cocci, 3 days after PST and focal laser for
DME. She responded to oral linezolid and topical moxi-
floxacin, with healed scar formation at 3 weeks. This was
the first ever reported case of bacterial scleral abscess after
PST in DME. Orbital abscess due to Scedosporium apiosper-
mum has been reported 3 months after PST given for DME.6
This case ultimately required pars plana vitrectomy for
endophthalmitis with good visual recovery of 6/12. Orbital
abscess following PST has been reported in cases of macular
edema following branch retinal venous occlusion.7 Scleral
abscess has also been reported after PST in uveitis with
cystoid macular edema.8 Kusaka et al.,9 reported orbital
infection due to Nocardia species 2 weeks after PST in a case
of Behcet disease. He was on systemic and topical steroids
and had uncontrolled diabetes. Subconjunctival mycetoma
due to Exophiala jeanselmei was noted by Galor et al.,10 after
1 week of PST for age related macular degeneration.
Steroids are known to promote bacterial and fungal infec-
tions especially in immunocompromised patients. Our case
is the second reported case of presumed bacterial scleral
abscess after PST injection in DME. In our case, most proba-
bly the causative organism was coagulase negative Staphylo-
coccus (Staphylococcus epidermidis), which is a known
commensal of the conjunctiva. The fungal orbital infections
after PST present late and usually have grave prognosis
unlike bacterial ones which present early and respond with
proper antibiotic. The infections most likely occur due to
commensals in conjunctiva in immunocompromised patients
(eg. poorly controlled diabetes), and when PST is given in
conjunction with laser. Systemic optimization with prompt
initiation of aggressive therapy can yield good response in
bacterial infections following PST. The risk of infection, bacte-
rial or fungal following PST should be always kept in mind.Conflict of interest
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